<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">2985117R</journal-id>
<journal-id journal-id-type="pubmed-jr-id">4816</journal-id>
<journal-id journal-id-type="nlm-ta">J Immunol</journal-id>
<journal-id journal-id-type="iso-abbrev">J. Immunol.</journal-id>
<journal-title-group>
<journal-title>Journal of immunology (Baltimore, Md. : 1950)</journal-title>
</journal-title-group>
<issn pub-type="ppub">0022-1767</issn>
<issn pub-type="epub">1550-6606</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27798153</article-id>
<article-id pub-id-type="pmc">5123839</article-id>
<article-id pub-id-type="doi">10.4049/jimmunol.1600383</article-id>
<article-id pub-id-type="manuscript">NIHMS820502</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>T-cell independent mechanisms associated with NETosis and selective autophagy in IL-17A-mediated epidermal hyperplasia</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Suzuki</surname>
<given-names>Erika</given-names>
</name>
<xref ref-type="aff" rid="A1">a</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Maverakis</surname>
<given-names>Emanual</given-names>
</name>
<xref ref-type="aff" rid="A2">c</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sarin</surname>
<given-names>Ritu</given-names>
</name>
<xref ref-type="aff" rid="A1">a</xref>
<xref ref-type="author-notes" rid="FN1">b</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bouchareychas</surname>
<given-names>Laura</given-names>
</name>
<xref ref-type="aff" rid="A1">a</xref>
<xref ref-type="author-notes" rid="FN1">b</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kuchroo</surname>
<given-names>Vijay K.</given-names>
</name>
<xref ref-type="aff" rid="A3">d</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Nestle</surname>
<given-names>Frank O.</given-names>
</name>
<xref ref-type="aff" rid="A4">e</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Adamopoulos</surname>
<given-names>Iannis E.</given-names>
</name>
<xref ref-type="aff" rid="A1">a</xref>
<xref ref-type="aff" rid="A5">f</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>a</label>Department of Internal Medicine, Division of Rheumatology, Allergy and Clinical Immunology, University of California at Davis, CA, 95616, USA</aff>
<aff id="A2"><label>c</label>Department of Dermatology, University of California at Davis, CA, 95616, USA</aff>
<aff id="A3"><label>d</label>Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA</aff>
<aff id="A4"><label>e</label>St. John’s Institute of Dermatology, Division of Genetics and Molecular Medicine, King’s College London School of Medicine, Guy’s Hospital, London, United Kingdom</aff>
<aff id="A5"><label>f</label>Institute for Pediatric Regenerative Medicine, Shriners Hospitals for Children Northern California, CA, 95817, USA</aff>
<author-notes>
<corresp id="cor1"><label>*</label><bold>Correspondence:</bold> Iannis E. Adamopoulos, Institute for Pediatric Regenerative Medicine, Shriners Hospitals for Children Northern California, 2425 Stockton Blvd, Sacramento, CA, 95817, USA. Tel: 916-453 2237 Fax: 916-453 2288. <email>iannis@ucdavis.edu</email></corresp>
<fn fn-type="equal" id="FN1">
<label>b</label>
<p id="P1">Authors contributed equally to the work described in this manuscript.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>12</day>
<month>10</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="epub">
<day>24</day>
<month>10</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="ppub">
<day>1</day>
<month>12</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>12</month>
<year>2017</year>
</pub-date>
<volume>197</volume>
<issue>11</issue>
<fpage>4403</fpage>
<lpage>4412</lpage>
<!--elocation-id from pubmed: 10.4049/jimmunol.1600383-->
<abstract>
<p id="P2">Interleukin 17A (IL-17A) has been strongly associated with epidermal hyperplasia in many cutaneous disorders. However, as IL-17A is mainly produced by αβ and γδT cells in response to IL-23, the role of T cells and IL-23 have overshadowed any IL-17A independent actions. Herein, we report that IL-17A gene transfer induces epidermal hyperplasia in <italic>Il23r</italic><sup>−/−</sup><italic>Rag1<sup>−/−</sup></italic> and <italic>Tcrδ</italic> deficient mice, which can be prevented by neutrophil depletion. Moreover adoptive transfer of CD11b<sup>+</sup>Gr-1<sup>hi</sup> cells, following IL-17A gene transfer, was sufficient to phenocopy the disease. We further show that the IL-17A-induced pathology was prevented in transgenic mice with impaired NETosis and/or neutrophils with conditional deletion of the master regulator of selective autophagy, <italic>Wdfy3</italic>. Our data demonstrate a novel T-cell independent mechanism that is associated with NETosis and selective autophagy in IL-17A-mediated epidermal hyperplasia.</p>
</abstract>
</article-meta>
</front>
</article>
</pmc-articleset>